These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 15791286)

  • 21. Lack of caspase-dependent apoptosis in spinal motor neurons of the wobbler mouse.
    Bigini P; Atzori C; Fumagalli E; Cagnotto A; Barbera S; Migheli A; Mennini T
    Neurosci Lett; 2007 Oct; 426(2):106-10. PubMed ID: 17890007
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Beyond Guam: the cyanobacteria/BMAA hypothesis of the cause of ALS and other neurodegenerative diseases.
    Bradley WG; Mash DC
    Amyotroph Lateral Scler; 2009; 10 Suppl 2():7-20. PubMed ID: 19929726
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Occurrence of beta-methylamino-l-alanine (BMAA) in ALS/PDC patients from Guam.
    Murch SJ; Cox PA; Banack SA; Steele JC; Sacks OW
    Acta Neurol Scand; 2004 Oct; 110(4):267-9. PubMed ID: 15355492
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early signs of motoneuron vulnerability in a disease model system: Characterization of transverse slice cultures of spinal cord isolated from embryonic ALS mice.
    Avossa D; Grandolfo M; Mazzarol F; Zatta M; Ballerini L
    Neuroscience; 2006; 138(4):1179-94. PubMed ID: 16442737
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serotonergic mechanisms in amyotrophic lateral sclerosis.
    Sandyk R
    Int J Neurosci; 2006 Jul; 116(7):775-826. PubMed ID: 16861147
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aberrant deltaPKC activation in the spinal cord of Wobbler mouse: a model of motor neuron disease.
    Dave KR; Raval AP; Purroy J; Kirkinezos IG; Moraes CT; Bradley WG; Pérez-Pinzón MA
    Neurobiol Dis; 2005 Feb; 18(1):126-33. PubMed ID: 15649703
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [An autopsy case of amyotrophic lateral sclerosis/parkinsonism-dementia complex with family history and living history in the Kii Peninsula focus].
    Konagaya M; Kato T; Sakai M; Kuru S; Matsuoka Y; Hashizume Y
    Rinsho Shinkeigaku; 1999 Nov; 39(11):1118-24. PubMed ID: 10689933
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of neurological disease in four dimensions: insight from ALS-PDC epidemiology and animal models.
    Shaw CA; Wilson JM
    Neurosci Biobehav Rev; 2003 Oct; 27(6):493-505. PubMed ID: 14599431
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Environmental neurotoxin-induced progressive model of parkinsonism in rats.
    Shen WB; McDowell KA; Siebert AA; Clark SM; Dugger NV; Valentino KM; Jinnah HA; Sztalryd C; Fishman PS; Shaw CA; Jafri MS; Yarowsky PJ
    Ann Neurol; 2010 Jul; 68(1):70-80. PubMed ID: 20582986
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lack of behavioral and neuropathological effects of dietary beta-methylamino-L-alanine (BMAA) in mice.
    Cruz-Aguado R; Winkler D; Shaw CA
    Pharmacol Biochem Behav; 2006 Jun; 84(2):294-9. PubMed ID: 16808967
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beta-amyloid 42 accumulation in the lumbar spinal cord motor neurons of amyotrophic lateral sclerosis patients.
    Calingasan NY; Chen J; Kiaei M; Beal MF
    Neurobiol Dis; 2005; 19(1-2):340-7. PubMed ID: 15837590
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A clinical and pathological study of a Japanese case of Amyotrophic Lateral Sclerosis/Parkinsonism-Dementia Complex with family history.
    Konagaya M; Kato T; Sakai M; Kuru S; Matsuoka Y; Konagaya Y; Hashizume Y; Tabira T
    J Neurol; 2003 Feb; 250(2):164-70. PubMed ID: 12574946
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The primary locus of motor neuron death in an ALS-PDC mouse model.
    Lee G; Chu T; Shaw CA
    Neuroreport; 2009 Sep; 20(14):1284-9. PubMed ID: 19633581
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic elevation of extracellular glutamate due to transport blockade is innocuous for spinal motoneurons in vivo.
    Tovar-Y-Romo LB; Santa-Cruz LD; Zepeda A; Tapia R
    Neurochem Int; 2009; 54(3-4):186-91. PubMed ID: 19100799
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A critical review of the postulated role of the non-essential amino acid, β-N-methylamino-L-alanine, in neurodegenerative disease in humans.
    Chernoff N; Hill DJ; Diggs DL; Faison BD; Francis BM; Lang JR; Larue MM; Le TT; Loftin KA; Lugo JN; Schmid JE; Winnik WM
    J Toxicol Environ Health B Crit Rev; 2017; 20(4):1-47. PubMed ID: 28598725
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Atypical parkinsonism of Japan: amyotrophic lateral sclerosis-parkinsonism-dementia complex of the Kii peninsula of Japan (Muro disease): an update.
    Kuzuhara S; Kokubo Y
    Mov Disord; 2005 Aug; 20 Suppl 12():S108-13. PubMed ID: 16092099
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis.
    Rothstein JD; Martin LJ; Kuncl RW
    N Engl J Med; 1992 May; 326(22):1464-8. PubMed ID: 1349424
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Animal models of BMAA neurotoxicity: a critical review.
    Karamyan VT; Speth RC
    Life Sci; 2008 Jan; 82(5-6):233-46. PubMed ID: 18191417
    [TBL] [Abstract][Full Text] [Related]  

  • 39. p53 is abnormally elevated and active in the CNS of patients with amyotrophic lateral sclerosis.
    Martin LJ
    Neurobiol Dis; 2000 Dec; 7(6 Pt B):613-22. PubMed ID: 11114260
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The ALS/PDC syndrome of Guam and the cycad hypothesis.
    Bradley WG; Banack SA; Cox PA
    Neurology; 2009 Feb; 72(5):473-4, 476; author reply 475-6. PubMed ID: 19195084
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.